+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pulmonary Drug Delivery Devices Market by Device Type, Therapy, Drug Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Pulmonary Drug Delivery Devices Market by Device Type, Therapy, Drug Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Pulmonary Drug Delivery Devices Market by Device Type, Therapy, Drug Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968897
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pulmonary drug delivery devices market is rapidly evolving, shaped by rising demand for innovative respiratory treatments, tighter regulatory standards, and shifts in global healthcare delivery. Senior leaders are re-evaluating portfolios and supply chains to capture growth and maintain clinical relevance as therapeutic requirements expand and digital health ecosystems mature.

Market Snapshot: Pulmonary Drug Delivery Devices Market

The Pulmonary Drug Delivery Devices Market grew from USD 52.99 billion in 2024 to USD 56.19 billion in 2025. With a projected CAGR of 5.94%, the market is expected to reach USD 74.93 billion by 2030. Critical market momentum is propelled by chronic lung disease prevalence, advances in inhaler design, and rapid adoption of patient-centered, propellant-free technologies. Innovation in both device engineering and digital health integration is establishing new benchmarks for efficiency, usability, and sustainability.

Scope & Segmentation

This report delivers comprehensive analysis and actionable segmentation relevant to device designers, manufacturers, and strategic partners across the global pulmonary drug delivery landscape:

  • Device Types: Dry Powder Inhalers (capsule-based, multi-dose reservoir, single-dose powder reservoir), Metered Dose Inhalers (CFC and HFA propellant), Nasal Sprays (propellant-based, pump actuator), Nebulizers (jet, mesh, ultrasonic), Soft Mist Inhalers
  • Therapies: Allergic Rhinitis, Asthma, Bronchiectasis, COPD, Cystic Fibrosis, Pulmonary Arterial Hypertension
  • Drug Types: Biologics (monoclonal antibodies, peptides, recombinant proteins), Combination Therapies (dual, triple, quad), Small Molecules, Vaccines (inactivated, live attenuated)
  • End Users: Hospitals, General Clinics, Respiratory Clinics, Home Healthcare, Specialty Centers
  • Distribution Channels: Offline Pharmacies (hospital, retail), Online Pharmacies (OTC e-commerce, prescription e-commerce)
  • Regions: Americas (United States and major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key countries spanning the UK, Germany, France, UAE, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, Southeast Asia, additional markets)
  • Notable Companies: GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Viatris Inc., Koninklijke Philips N.V., Becton, Dickinson and Company, 3M Company, AptarGroup, Inc.

Key Takeaways for Senior Decision-Makers

  • Demand for propellant-free and digitally enabled inhalation devices is intensifying, driven by regulatory mandates and patient preferences for sustainable, user-friendly solutions.
  • Personalized medicine is altering device design, with smart inhalers and integrated sensors supporting individual patient monitoring and improved adherence to complex therapy regimens.
  • Emerging biological formulations and combination therapies require high-precision drug-device integration and robust real-world validation, particularly in chronic and rare pulmonary conditions.
  • Growth in the Asia-Pacific region is underpinned by large patient populations, government healthcare investments, and increasing acceptance of portable nebulizers and telehealth-enabled devices.
  • Competitive differentiation is accelerating through partnerships between device manufacturers and digital health firms, enabling rapid updates to device platforms and seamless data collection for clinical management.
  • Segment-specific strategies addressing both home-based care and traditional hospital environments are crucial as outpatient and self-administration trends continue to expand globally.

Tariff Impact

Recent US tariff implementations have increased component costs for inhalers and related electronics, compelling manufacturers to adapt procurement and sourcing strategies. Responses include domestic assembly, diversification of supply chains toward Southeast Asia and Latin America, and modular product architectures accommodating regional parts without requalification disruptions. This adaptation requires ongoing policy monitoring and operational flexibility, ensuring both resilience and compliance amid evolving global trade dynamics.

Methodology & Data Sources

This report utilizes a robust mixed-method approach, blending in-depth primary interviews with over fifty industry stakeholders and secondary analysis of clinical trial databases, regulatory filings, and proprietary health outcomes datasets. Peer-reviewed validation processes and continual editorial checks ensure reliable, actionable intelligence for cross-functional strategic planning.

Why This Report Matters

  • Equip executive and commercial teams with validated insights into competitive positioning, future-ready devices, and high-value therapy segments.
  • Support capital allocation, product development, and go-to-market strategies with context on disruptive trends, regional priorities, and operational risks.
  • Enable regulatory, sourcing, and R&D leaders to proactively respond to evolving standards, tariff pressures, and sustainability demands across target geographies.

Conclusion

The pulmonary drug delivery devices market is undergoing substantial transformation, driven by innovation, regulatory shifts, and an expanding care continuum. Decision-makers leveraging this intelligence will be positioned to anticipate market needs, optimize portfolios, and sustain growth across regional and therapeutic segments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pulmonary Drug Delivery Devices Market, by Device Type
8.1. Introduction
8.2. Dry Powder Inhaler
8.2.1. Capsule Based
8.2.2. Multi Dose Reservoir
8.2.3. Single Dose Powder Reservoir
8.3. Metered Dose Inhaler
8.3.1. CFC Propellant
8.3.2. HFA Propellant
8.4. Nasal Spray
8.4.1. Propellant Based
8.4.2. Pump Actuator
8.5. Nebulizer
8.5.1. Jet Nebulizer
8.5.2. Mesh Nebulizer
8.5.3. Ultrasonic Nebulizer
8.6. Soft Mist Inhaler
9. Pulmonary Drug Delivery Devices Market, by Therapy
9.1. Introduction
9.2. Allergic Rhinitis
9.3. Asthma
9.4. Bronchiectasis
9.5. COPD
9.6. Cystic Fibrosis
9.7. Pulmonary Arterial Hypertension
10. Pulmonary Drug Delivery Devices Market, by Drug Type
10.1. Introduction
10.2. Biologics
10.2.1. Monoclonal Antibody
10.2.2. Peptide
10.2.3. Recombinant Proteins
10.3. Combination Therapy
10.3.1. Dual Combination
10.3.2. Quad Combination
10.3.3. Triple Combination
10.4. Small Molecule
10.5. Vaccines
10.5.1. Inactivated
10.5.2. Live Attenuated
11. Pulmonary Drug Delivery Devices Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Respiratory Clinics
11.3. Home Healthcare
11.4. Hospitals
11.5. Specialty Centers
12. Pulmonary Drug Delivery Devices Market, by Distribution Channel
12.1. Introduction
12.2. Offline Pharmacies
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.3. Online Pharmacies
12.3.1. OTC Ecommerce
12.3.2. Prescription Ecommerce
13. Americas Pulmonary Drug Delivery Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pulmonary Drug Delivery Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. AstraZeneca plc
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Novartis AG
16.3.6. Viatris Inc.
16.3.7. Koninklijke Philips N.V.
16.3.8. Becton, Dickinson and Company
16.3.9. 3M Company
16.3.10. AptarGroup, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PULMONARY DRUG DELIVERY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. PULMONARY DRUG DELIVERY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. PULMONARY DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PULMONARY DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 98. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 100. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 101. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 102. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 103. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 104. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 106. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 107. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 108. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 112. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 116. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 118. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 119. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 122. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 127. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 190. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 191. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 192. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 193. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 194. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 195. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 197. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 198. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 206. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 207. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 208. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 210. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 211. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 213. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 235. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 236. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 237. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 238. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 239. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 240. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 241. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 242. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 243. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 244. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 246. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 252. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 253. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 254. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 255. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 256. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 258. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 259. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 261. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 263. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (U

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pulmonary Drug Delivery Devices market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Viatris Inc.
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • 3M Company
  • AptarGroup, Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 56.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 74.93 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pulmonary Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Pulmonary Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Pulmonary Drug Delivery Systems Market Size, Share & Trends Analysis Report by Product (Inhalers, Nebulizers, Accessories), Application (Asthma, Cystic Fibrosis), End-use, Region and Segment Forecasts, 2024-2030 - Product Image

Pulmonary Drug Delivery Systems Market Size, Share & Trends Analysis Report by Product (Inhalers, Nebulizers, Accessories), Application (Asthma, Cystic Fibrosis), End-use, Region and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Pulmonary Drug Delivery Devices Market Report 2025 - Product Image

Pulmonary Drug Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pulmonary or Respiratory Drug Delivery Market Report 2025 - Product Image

Pulmonary or Respiratory Drug Delivery Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Aerosol Drug Delivery Devices Market Size, Share & Trends Analysis Report by Type (Inhaler, Nebulizer), Application (COPD, Asthma, Cystic Fibrosis), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Aerosol Drug Delivery Devices Market Size, Share & Trends Analysis Report by Type (Inhaler, Nebulizer), Application (COPD, Asthma, Cystic Fibrosis), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.